Global Azacitidine Market, Size, Share, Analysis Report & Forecast to 2026


Posted October 14, 2021 by alfahadkhan2510

The global azacitidine market is anticipated to grow at a CAGR of 4.95 % during the forecast period.

 
The global azacitidine market is anticipated to grow at a CAGR of 4.95 % during the forecast period. The primary factor contributing to the growth of the market is the increasing incidence of chronic diseases such as cancer, acute leukaemia, and cerebrovascular diseases. According to the WHO, in 2019, around 6.6 million deaths were caused due to cerebrovascular diseases globally. Due to this increasing burden of the disease, it is expected to fuel the growth of the market during the forecast period.

Free Sample Copy @ https://www.omrglobal.com/request-sample/azacitidine-market

Azacitidine is a chemotherapy drug that is used for the treatment of blood and bone marrow diseases. It is a condition where bone marrow is not able to produce new cells. The increasing prevalence of disorders like breast cancer and melanoma across the globe will fuel the demand for the drug during the forecast period. More shifts towards chemotherapy rather than using blood transfusion for the treatment is also one of the factors that will propel the growth of the market.

A Full Report of Global Azacitidine Market is Available at:
https://www.omrglobal.com/industry-reports/azacitidine-market

Some of the key global players in the global azacitidine market include Eisai Co. Ltd., Pfizer, Inc., Sanofi, Teva Pharmaceuticals Industries Ltd., Novartis AG, Intas Pharmaceuticals Ltd., and many others. For instance, in September 2021, Intas Pharmaceuticals Ltd. launched India’s first oral therapy drug called Azdadine-O. The drug will be used for the treatment of myeloid leukaemia and can improve the patients’ chances of survival by 10 months while avoiding the need for cancer therapy.

Global Azacitidine Market – Segmentation
By Application
Refractory anaemia
Chronic myelomonocytic leukaemia
By Route of Administration
Oral
Injectable
Others
By End-User
Hospitals
Home care
Speciality clinics
Others

Global Azacitidine Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Eisai Co. Ltd.
Pfizer Inc.
Sanofi
Teva Pharmaceuticals Industries Ltd.
Novartis AG
Intas Pharmaceuticals Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/azacitidine-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Alfahad khan
Phone +91 780-304-0404
Country India
Categories Business
Tags global azacitidine market
Last Updated October 14, 2021